IFAA: 1 of 3 Winners of the 2015 Celgene Innovation Impact Awards
A Community Team (ACT): Redefining Research is designed to gather a global pool of patients, industry and researchers to initiate discussions early in the drug discovery environment so that research ideas and dollars spent will better reflect the patient’s needs. The program enables patients who are usually unable to participate in research discussions due to disease limitations and/or the inability to travel, to contribute through a flexible virtual platform. The process will be 'blueprinted' so it can be used for future expansion with other diseases. LEARN MORE
The International Foundation for Autoimmune Arthritis is ranked a Gold Level Participant with GuideStar.
We are a TEAM of passionate patients and patient supporters who united to identify and solve community gaps and problems of unmet needs.
IFAA continuously analyzes the community, through internal investigations and patient to patient communications, to determine the most pressing issues patients face today. Then, using our backgrounds in business and education, we work to develop and implement solutions.
IFAA Co-Founders Advisory Committee Members for Innovative Industry-Academic Institutions-Patient Organizations Collaboration
In April 2016 PACT launched at the iBIO Index convention and IFAA was present for it's inception. The mission of PACT is to connect local, regional and national organizations by appropriately engaging key stakeholders to advance the shared goal of bringing new treatments to patients more efficiently. LEARN MORE
#LearnArthritis: Global health campaign to understand the differences in arthritis types
The pledge is on! Starting on May 19th we ask you to help us attempt a GUINNESS WORLD RECORDS® achievement for "Most pledges for a health campaign": #LearnArthritis. Help us beat the current record of 27,457 pledges before August 31st: LEARN MORE
IFAA and Team Shows Why Step Therapy Has Ethical Implications and Must Be Modernized
IFAA led a six month investigation into the ethics of step therapy, assisted by bioethicist consultants and Kathleen Arntsen, President & CEO of the Lupus & Allied Diseases Association, Inc. (LADA), as the public policy advisor. LEARN MORE
Copyright 2016. All rights reserved. Information on this site is intended for informational purposes only Our foundation does not engage in the practice of medicine. Please consult a physician to obtain personal healthcare and treatment options. Tax ID: 27-1214308